View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pertuzumab 840 / Trastuzumab 8, Salivary Gland Tumor, Cycle 1
Protocol-ID: 1701 V1.0 (Mini), PERT840/TRAS8, salivary gland tumor, C1Indication(s)
- Salivary Gland Tumor (HER2+); ICD-10 C08.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 16.01.2021